GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28652
Submission : 2014-09-17
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16498
Submission : 2003-03-25
Status : Inactive
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16498
Submission : 2003-03-25
Status : Inactive
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28652
Submission : 2014-09-17
Status : Active
Type : IV
FINISHED DOSAGE FORMULATIONS
Drug : TRETINOIN
Dosage Form : CREAM; TOPICAL
Application Number : 90098
Country : US
Patented : No
Drug : TRETINOIN
Dosage Form : CREAM; TOPICAL
Application Number : 202209
Country : US
Patented : No
Drug : SSD AF
Dosage Form : CREAM; TOPICAL
Application Number : 18578
Country : US
Patented : No
Drug : SSD
Dosage Form : CREAM; TOPICAL
Application Number : 18578
Country : US
Patented : No
Drug : HYDROCORTISONE
Dosage Form : CREAM; TOPICAL
Application Number : 89682
Country : US
Patented : No
Drug : XERESE
Dosage Form : CREAM; TOPICAL
Application Number : 22436
Country : US
Patented : No
Drug : RETIN-A
Dosage Form : CREAM; TOPICAL
Application Number : 19049
Country : US
Patented : No
Drug : ANDROGEL
Dosage Form : GEL; TRANSDERMAL
Application Number : 22309
Country : US
Patented : Yes
Drug : ANDROGEL
Dosage Form : GEL, METERED; TRANSDERMAL
Application Number : 21015
Country : US
Patented : No
Drug : FENTANYL-62
Dosage Form : FILM, EXTENDED RELEASE; TRANSDERMAL
Application Number : 77449
Country : US
Patented : No
ISOPROPYL MYRISTATE
Route : AURICULAR (OTIC)
CAS : 110-27-0
UNII : 0RE8K4LNJS
Potency Amount : 0.024
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ISOPROPYL MYRISTATE
Route : TOPICAL
CAS : 110-27-0
UNII : 0RE8K4LNJS
Potency Amount : 9.3
Potency Unit : %W/W
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ISOPROPYL MYRISTATE
Route : TOPICAL
CAS : 110-27-0
UNII : 0RE8K4LNJS
Potency Amount : 0
Potency Unit : NA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ISOPROPYL MYRISTATE
Route : TOPICAL
CAS : 110-27-0
UNII : 0RE8K4LNJS
Potency Amount : 8
Potency Unit : %W/W
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ISOPROPYL MYRISTATE
Route : TOPICAL
CAS : 110-27-0
UNII : 0RE8K4LNJS
Potency Amount : 5
Potency Unit : %W/W
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ISOPROPYL MYRISTATE
Route : TOPICAL
CAS : 110-27-0
UNII : 0RE8K4LNJS
Potency Amount : 10
Potency Unit : %W/W
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ISOPROPYL MYRISTATE
Route : TOPICAL
CAS : 110-27-0
UNII : 0RE8K4LNJS
Potency Amount : 7.9
Potency Unit : %W/W
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ISOPROPYL MYRISTATE
Route : TOPICAL
CAS : 110-27-0
UNII : 0RE8K4LNJS
Potency Amount : 15
Potency Unit : %W/W
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ISOPROPYL MYRISTATE
Route : TOPICAL
CAS : 110-27-0
UNII : 0RE8K4LNJS
Potency Amount : 1
Potency Unit : %W/V
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ISOPROPYL MYRISTATE
Route : TOPICAL
CAS : 110-27-0
UNII : 0RE8K4LNJS
Potency Amount : 10
Potency Unit : %W/W
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
REF. STANDARDS & IMPURITIES